Abstract
AIM: We aimed to describe and contrast the epidemiology of haematological malignancies among 0-14 and 15-24-year-olds in northern England from 1990 to 2002 and compare clinical trial entry by age group.
PATIENTS AND METHODS: Incidence rates were examined by age, sex and period of diagnosis and differences were tested using Poisson regression. Differences and trends in survival were assessed using Cox regression.
RESULTS: 1680 subjects were included comprising 948 leukaemias and 732 lymphomas. Incidence rates for acute lymphoblastic leukaemia were significantly higher for 0-14 compared to 15-24-year-olds, whilst Hodgkin lymphoma showed the reverse. No significant changes in incidence were observed. 60% of leukaemia patients aged 15-24 years entered trials compared to 92% of 0-14-year-olds. Survival rates were significantly lower and improved less markedly over time for 15-24 compared to 0-14-year-olds, particularly for leukaemia.
CONCLUSIONS: Trial accrual rates need to be improved amongst 15-24-year-olds and a more structured follow-up approach adopted for this unique population.
Original language | English |
---|---|
Pages (from-to) | 420-7 |
Number of pages | 8 |
Journal | European Journal of Cancer |
Volume | 45 |
Issue number | 3 |
DOIs | |
Publication status | Published - Feb 2009 |
Externally published | Yes |
Keywords
- Adolescent
- Age Distribution
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Child
- Child, Preschool
- England/epidemiology
- Female
- Humans
- Incidence
- Infant
- Infant, Newborn
- Leukemia/epidemiology
- Lymphoma/epidemiology
- Male
- Quality of Life/psychology
- Registries
- Sex Distribution
- Survival Rate/trends
- Young Adult